CBL and breast carcinoma: Mechanistic studies revealed that miR-124-3p directly binds the CBL 3’-UTR and inhibit CBL expression, and that CBL overexpression sufficiently attenuates the inhibitory effects of miR-124-3p on breast cancer cell proliferation and invasion.